M4MM
Hemp-Derived THC Beverages Gain Traction as U.S. Alcohol Consumption Declines
LOS ANGELES – Hemp-derived THC beverages generated $382 million in sales in 2024, a marked increase from previous years, yet 2025 projections indicate tempered growth at $571 million, climbing to $756 million by 2029 with ...
Crafting Cannabis Excellence: How Quality Builds Lasting Brands
In the bustling Cannabis market, where fierce competition and economic pressures have driven prices down, many products risk blending into a sea of sameness. Yet, a select group of companies stands out by prioritizing premium ...
Cannabis Legalization Drives Property Growth, Research Finds
LOS ANGELES – The legalization of recreational Cannabis has had a substantial positive impact on home values across the United States, effectively dispelling myths that it harms property markets. From 2009 to 2024, homes in ...
Thai Cannabis Stores Face Uncertainty as Government Tightens Sales Regulations
LOS ANGELES- Thailand’s government has introduced a new order—published in the Royal Gazette on June 26, 2025—mandating that cannabis can now only be sold with a valid medical prescription from licensed practitioners. Cannabis buds have been reclassified ...
Cybin Secures Up to US $500 Million via Convertible Debentures to Fuel Clinical Growth
LOS ANGELES- Cybin Inc. has entered into a securities purchase agreement with High Trail Special Situations LLC to raise up to US $500 million through unsecured convertible debentures, aiming to strengthen its position in neuropsychiatric therapeutics ...
Atai and Beckley Psytech Report Positive Phase 2b Results for BPL‑003
LOS ANGELES- Atai Life Sciences and Beckley Psytech have announced positive topline results from their Phase 2b clinical trial of BPL‑003, an intranasal formulation of mebufotenin benzoate, in patients with treatment‑resistant depression (TRD). The multicenter, ...
iAnthus Reports Unanimous Approval at Annual General Meeting
LOS ANGELES- iAnthus Capital Holdings, a multi-state operator in licensed cannabis cultivation, processing, and retail, announced that its shareholders unanimously approved all items at the Annual General Meeting held on June 26, 2025. The approved resolutions included ...
Hemp-Derived THC Beverages Gain Traction as U.S. Alcohol Consumption Declines
LOS ANGELES – Hemp-derived THC beverages generated $382 million in sales in 2024, a marked increase from previous years, yet 2025 projections indicate tempered growth at $571 million, climbing to $756 million by 2029 with ...
Crafting Cannabis Excellence: How Quality Builds Lasting Brands
In the bustling Cannabis market, where fierce competition and economic pressures have driven prices down, many products risk blending into a sea of sameness. Yet, a select group of companies stands out by prioritizing premium ...
Cannabis Legalization Drives Property Growth, Research Finds
LOS ANGELES – The legalization of recreational Cannabis has had a substantial positive impact on home values across the United States, effectively dispelling myths that it harms property markets. From 2009 to 2024, homes in ...
Compass Pathways Launches UK Phase of Landmark Psilocybin Study for Treatment-Resistant Depression
NEW YORK- Compass Pathways plc (Nasdaq: CMPS), a biotechnology leader dedicated to advancing mental health treatments, has announced the initiation of the UK component of its phase 3 program investigating COMP360 psilocybin treatment for treatment-resistant ...
Alabama Medical Cannabis Commission Settles Lawsuits
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has made significant strides this week by reaching a settlement with license applicants, a move aimed at resolving the multiple lawsuits filed against the agency. This development, ...
Swedish Researchers Use Psychedelics to Explore Brain Function and AI Development
LOS ANGELES- In a groundbreaking study at Lund University in Sweden, researchers are employing psychedelic substances, specifically acid (LSD) and ketamine, to delve into the intricate workings of the brain. This unique approach aims to ...
Minnesota Tests New Saliva-Based Roadside Cannabis Impairment Assessment
LOS ANGELES- In a groundbreaking move, Minnesota's Office of Traffic Safety (OTS) has initiated a pilot program to test a saliva-based roadside cannabis impairment test. This innovative approach is designed to enhance the state's capabilities ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis dispensaries have achieved over $100 million in adult-use sales, ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development of innovative psychedelic treatments. The company announced the closure ...
Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq Regulations
NEW YORK- Clearmind Medicine Inc., a biotech company renowned for its innovative work in developing psychedelic-derived therapeutics, has announced a strategic decision to conduct a reverse share split of its ordinary shares. This move is ...
Revive Therapeutics Advances Development of Innovative Bucillamine Formulation for Medical Emergencies
LOS ANGELES- Revive Therapeutics Ltd, a specialty life sciences company, has recently announced significant progress in the development of a new lyophilized formulation of Bucillamine, a drug initially designed for medical needs and rare disorders. ...
Oklahoma Prolongs Medical Cannabis License Moratorium to 2026 Amid Regulatory Review
LOS ANGELES- In a significant move for the state's cannabis industry, Oklahoma has decided to extend its moratorium on new medical cannabis licenses up to 2026, as reported by Tulsa World. This extension hinges on ...
New York Sets Stringent Regulations on Hemp Products, Banning Delta-8 and Other THC Variants
NEW YORK- New York's cannabis regulatory framework has reached a new milestone with the finalization of rules governing intoxicating hemp products. The state's regulators have imposed a ban on specific THC variants, including Delta-8 THC, ...
Pennsylvania Moves to Expand Medical Cannabis Retail Access, Breaking Up Potential Monopoly
NEW YORK- Pennsylvania is poised to significantly expand its medical cannabis industry, with new legislation on the horizon that could allow all of its 25 medical cannabis grower/processor licensees to also operate retail outlets. This ...
California Regulators Impose Embargo on Cannabis Products from Three Companies Over Safety Concerns
LOS ANGELES- California's Department of Cannabis Control (DCC) has taken decisive action by imposing an embargo on cannabis products from three companies, citing concerns that these products may have been "adulterated" and potentially harmful. This ...
South Dakota on the Cusp of Major Cannabis Reform with New Adult-Use Ballot Initiatives
LOS ANGELES- In a significant development for cannabis legislation, South Dakota has introduced two new adult-use cannabis legalization measures, aiming for inclusion in the 2024 general election. Both initiatives require 17,509 valid signatures from registered ...
Navigating the Green: Unraveling the Taxing Dilemma in the Cannabis Industry
LOS ANGELES- In the ever-expanding landscape of the cannabis industry, where green is not just a color but a thriving economic force, the question of taxation looms large. As states grapple with the complex task ...
Silo Pharma Secures Exclusive License for MedSpray’s Intranasal Technology for SPC-15 Drug Delivery
NERW YORK – Silo Pharma, Inc. a biopharmaceutical company at the forefront of merging traditional therapeutics with psychedelic research, announced today its new exclusive licensing agreement with Medspray Pharma BV. This agreement centers around Medspray's ...
